Douglas CDMO Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

Douglas CDMO assists pharmaceutical and biotechnology companies with their contract manufacturing and development needs, specializing in high-potency softgels and liquids. They have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity. Douglas is one of the primary suppliers of pharmaceutical softgels to the United States and European markets. Alongside a commitment to delivering high quality products, Douglas CDMO prioritizes excellent service, aiming to be a preferred CDMO partner for ease of doing business, responsiveness and problem-solving.

Lora Wallis and Chris Cuthbertson will share Douglas CDMO’s capacity and unique capabilities, highlighting its strengths in high-potency softgels and liquids. Douglas CDMO has 67 years of expertise and a client-centric approach; large enough to provide technical depth and scale, yet focused enough to offer a personalized end-to-end service.